Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21


Surface Nanopore Engineering of 2D MXenes for Targeted and Synergistic Multitherapies of Hepatocellular Carcinoma.

Li Z, Zhang H, Han J, Chen Y, Lin H, Yang T.

Adv Mater. 2019 Jul;31(27):e1902282. doi: 10.1002/adma.201902282. No abstract available.


Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma.

Cai Z, Chen G, Zeng Y, Dong X, Li Z, Huang Y, Xin F, Qiu L, Xu H, Zhang W, Su X, Liu X, Liu J.

Clin Cancer Res. 2019 Sep 1;25(17):5284-5294. doi: 10.1158/1078-0432.CCR-18-3477. Epub 2019 Jun 19.


Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.

Xing H, Qiu H, Ding X, Han J, Li Z, Wu H, Yan C, Li H, Han R, Zhang H, Li C, Wang M, Wu M, Shen F, Zheng Y, Yang T.

Biomark Med. 2019 May;13(7):545-555. doi: 10.2217/bmm-2018-0414. Epub 2019 May 29.


High expression of B7‑H2 or B7‑H3 is associated with poor prognosis in hepatocellular carcinoma.

Zheng Y, Liao N, Wu Y, Gao J, Li Z, Liu W, Wang Y, Li M, Li X, Chen L, Zhang W, Zhao B.

Mol Med Rep. 2019 May;19(5):4315-4325. doi: 10.3892/mmr.2019.10080. Epub 2019 Mar 22.


Genomic and transcriptional Profiling of tumor infiltrated CD8+ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.

Li Z, Chen G, Cai Z, Dong X, Qiu L, Xu H, Zeng Y, Liu X, Liu J.

Oncoimmunology. 2018 Nov 10;8(2):e1538436. doi: 10.1080/2162402X.2018.1538436. eCollection 2019.


High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.

Li C, Bu J, Liao Y, Zhang J, Han J, Zhang H, Xing H, Li Z, Wu H, Liang L, Wang M, Qin W, Yang T.

Cell Physiol Biochem. 2018;51(6):2829-2842. doi: 10.1159/000496013. Epub 2018 Dec 18.


Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.

Qiu L, Huang Y, Li Z, Dong X, Chen G, Xu H, Zeng Y, Cai Z, Liu X, Liu J.

Mol Oncol. 2019 Feb;13(2):441-455. doi: 10.1002/1878-0261.12424. Epub 2019 Jan 9.


Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.

Ke K, Chen G, Cai Z, Huang Y, Zhao B, Wang Y, Liao N, Liu X, Li Z, Liu J.

Cancer Manag Res. 2018 Nov 5;10:5291-5302. doi: 10.2147/CMAR.S178579. eCollection 2018.


Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.

Chen G, Cai Z, Li Z, Dong X, Xu H, Lin J, Chen L, Zhang H, Liu X, Liu J.

Int J Cancer. 2018 Dec 1;143(11):2862-2870. doi: 10.1002/ijc.31844. Epub 2018 Oct 3.


CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.

Dong X, Chen G, Cai Z, Li Z, Qiu L, Xu H, Yuan Y, Liu XL, Liu J.

Cell Physiol Biochem. 2018;47(6):2602-2612. doi: 10.1159/000491656. Epub 2018 Jul 11.


Surface Nanopore Engineering of 2D MXenes for Targeted and Synergistic Multitherapies of Hepatocellular Carcinoma.

Li Z, Zhang H, Han J, Chen Y, Lin H, Yang T.

Adv Mater. 2018 Jun;30(25):e1706981. doi: 10.1002/adma.201706981. Epub 2018 Apr 16. Erratum in: Adv Mater. 2019 Jul;31(27):e1902282.


The polymorphism rs671 at ALDH2 associated with serum uric acid levels in Chinese Han males: A genome-wide association study.

Zhang D, Yang M, Zhou D, Li Z, Cai L, Bao Y, Li H, Shan Z, Liu J, Lv D, Liu Y, Xu C, Ling J, Xu Y, Zhang S, Huang Q, Shi Y, Zhu Y, Lai M.

Gene. 2018 Apr 20;651:62-69. doi: 10.1016/j.gene.2018.01.064. Epub 2018 Feb 7.


Deletions at SLC18A1 increased the risk of CRC and lower SLC18A1 expression associated with poor CRC outcome.

Zhang D, Li Z, Xu X, Zhou D, Tang S, Yin X, Xu F, Li H, Zhou Y, Zhu T, Deng H, Zhang S, Huang Q, Wang J, Yin W, Zhu Y, Lai M.

Carcinogenesis. 2017 Oct 26;38(11):1057-1062. doi: 10.1093/carcin/bgx088.


Reconstructing Lineage Hierarchies of Mouse Uterus Epithelial Development Using Single-Cell Analysis.

Wu B, An C, Li Y, Yin Z, Gong L, Li Z, Liu Y, Heng BC, Zhang D, Ouyang H, Zou X.

Stem Cell Reports. 2017 Jul 11;9(1):381-396. doi: 10.1016/j.stemcr.2017.05.022. Epub 2017 Jun 15.


Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study.

Zhu Y, Zhang D, Zhou D, Li Z, Li Z, Fang L, Yang M, Shan Z, Li H, Chen J, Zhou X, Ye W, Yu S, Li H, Cai L, Liu C, Zhang J, Wang L, Lai Y, Ruan L, Sun Z, Zhang S, Wang H, Liu Y, Xu Y, Ling J, Xu C, Zhang Y, Lv D, Yuan Z, Zhang J, Zhang Y, Shi Y, Lai M.

J Cell Mol Med. 2017 Jun;21(6):1106-1116. doi: 10.1111/jcmm.13042. Epub 2017 Mar 30.


Dysregulated fatty acid metabolism in hepatocellular carcinoma.

Wang M, Han J, Xing H, Zhang H, Li Z, Liang L, Li C, Dai S, Wu M, Shen F, Yang T.

Hepat Oncol. 2016 Oct;3(4):241-251. doi: 10.2217/hep-2016-0012. Epub 2017 Jun 30. Review.


Polymorphisms involving gain or loss of CpG sites are significantly enriched in trait-associated SNPs.

Zhou D, Li Z, Yu D, Wan L, Zhu Y, Lai M, Zhang D.

Oncotarget. 2015 Nov 24;6(37):39995-40004. doi: 10.18632/oncotarget.5650.


A genome-wide assessment of rare copy number variants in colorectal cancer.

Li Z, Yu D, Gan M, Shan Q, Yin X, Tang S, Zhang S, Shi Y, Zhu Y, Lai M, Zhang D.

Oncotarget. 2015 Sep 22;6(28):26411-23. doi: 10.18632/oncotarget.4621.


Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.

Yu D, Li Z, Gan M, Zhang H, Yin X, Tang S, Wan L, Tian Y, Zhang S, Zhu Y, Lai M, Zhang D.

Tumour Biol. 2015 Nov;36(11):8531-5. doi: 10.1007/s13277-015-3588-7. Epub 2015 Jun 2.


Interactions between obesity-related copy number variants and dietary behaviors in childhood obesity.

Zhang D, Li Z, Wang H, Yang M, Liang L, Fu J, Wang C, Ling J, Zhang Y, Zhang S, Xu Y, Zhu Y, Lai M.

Nutrients. 2015 Apr 22;7(4):3054-66. doi: 10.3390/nu7043054.

Supplemental Content

Loading ...
Support Center